Prestige Consumer Healthcare PBH Business Segments
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Business | ||||||
| International OTC Healthcare | $47.07M-1.0% | $47.75M-7.1% | $43.36M-1.4% | $36.95M+6.1% | $47.57M+3.7% | |
| North American OTC Healthcare | $234.55M-5.8% | $235.7M-1.4% | $230.76M-3.8% | $212.58M-8.5% | $248.95M+7.7% | |
| Gross Profit by Business | ||||||
| International OTC Healthcare | $24.93M-12.6% | $26.67M-11.6% | $23.17M-8.6% | $19.93M+3.5% | $28.52M+8.0% | |
| North American OTC Healthcare | $121.37M-14.2% | $130.7M-0.1% | $128.41M-2.7% | $120.4M-5.0% | $141.49M+12.8% | |
| Contribution Margin by Business | ||||||
| International OTC Healthcare | $17.01M-20.2% | $19.31M-16.9% | $16.5M-12.4% | $13.95M+2.2% | $21.31M+8.3% | |
| North American OTC Healthcare | $94.2M-15.7% | $98.01M-1.9% | $96.38M-0.8% | $91.45M-1.7% | $111.69M+18.1% | |
| Goodwill, Gross by Business | ||||||
| International OTC Healthcare | $31.71M+5.4% | $31.26M+4.7% | $31.06M-2.6% | $30.97M-0.4% | $30.08M-1.0% | |
| North American OTC Healthcare | $763.5M+7.3% | $764.09M+7.4% | $711.45M0.0% | $711.45M0.0% | $711.45M0.0% | |
| Cost of Sales by Business | ||||||
| International OTC Healthcare | $22.15M+16.3% | $21.07M-0.6% | $20.19M+8.4% | $17.02M+9.4% | $19.05M-2.1% | |
| North American OTC Healthcare | $113.17M+5.3% | $105M-2.8% | $102.35M-5.0% | $92.18M-12.7% | $107.46M+1.6% | |
| Goodwill, Impaired, Accumulated Impairment Loss by Business | ||||||
| International OTC Healthcare | $1.59M0.0% | $1.59M0.0% | $1.59M0.0% | $1.59M0.0% | $1.59M0.0% | |
| North American OTC Healthcare | $212.52M0.0% | $212.52M0.0% | $212.52M0.0% | $212.52M0.0% | $212.52M0.0% | |
| Advertising and marketing by Business | ||||||
| International OTC Healthcare | $7.92M+9.8% | $7.37M+6.0% | $6.67M+2.3% | $5.98M+6.6% | $7.21M+7.1% | |
| North American OTC Healthcare | $27.17M-8.8% | $32.69M+5.5% | $32.03M-8.2% | $28.95M-14.2% | $29.79M-3.2% | |
| Additions by Business | ||||||
| International OTC Healthcare | $0— | —— | —— | —— | —— | |
| North American OTC Healthcare | $133K— | —— | —— | —— | $0— | |
| Effects of foreign currency exchange rates by Business | ||||||
| International OTC Healthcare | $449K— | $198K+110% | $97K-87.6% | $889K+122% | —— | |
| North American OTC Healthcare | -$721K— | $0— | $0— | $0— | $0— | |
| Goodwill by Business | ||||||
| International OTC Healthcare | $30.12M+5.7% | $29.67M+4.9% | $29.48M-2.7% | $29.38M-0.4% | $28.49M-1.1% | |
| North American OTC Healthcare | $550.99M+10.4% | $551.58M+10.6% | $498.94M0.0% | $498.94M0.0% | $498.94M0.0% | |
| Total revenues by Product | ||||||
| Analgesics | $28.24M-6.5% | $28.03M-9.5% | $28.73M+1.8% | $28.93M+2.3% | $30.2M+8.6% | |
| Cough & Cold | $26.29M-2.3% | $29.33M0.0% | $27.29M-6.8% | $19.01M-8.2% | $26.91M+2.8% | |
| Dermatologicals | $30.49M+4.8% | $29.64M-3.3% | $35.7M-0.4% | $30.11M-9.7% | $29.08M-5.7% | |
| Eye & Ear Care | $37.85M-19.0% | $38.6M-15.5% | $34.18M-20.1% | $32.31M-32.9% | $46.73M+6.2% | |
| Gastrointestinal | $68.35M-0.8% | $69.45M+0.7% | $64.2M+6.9% | $57.78M-0.4% | $68.88M+15.5% | |
| Oral Care | $28M+3.3% | $26.58M+15.2% | $24.77M+2.8% | $21.7M+4.5% | $27.09M+7.0% | |
| Other OTC | $5.35M+39.2% | $4.04M+16.3% | $3.06M-3.0% | $2.93M-11.2% | $3.85M+25.3% | |
| Women's Health | $57.05M-10.6% | $57.77M-0.6% | $56.2M-6.9% | $56.76M+4.0% | $63.78M+6.0% | |
| Concentration risk, percentage by Product | ||||||
| Manufacturers | 15%+0.5pp | 15%+0.5pp | 15%+0.5pp | 15%+0.5pp | 14.5%-3.5pp | |
| Manufacturers, United States, Canada and Australia | 5.3%— | 5.3%— | 5.3%— | 5.3%— | —— | |
| Percentage of deposits held in one location (as percent) by Geography | ||||||
| Singapore | 4%+3.0pp | —— | —— | —— | 1%-1.0pp | |
| Sydney, Australia | 18%+7.0pp | —— | —— | —— | 11%-38.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Prestige Consumer Healthcare break its business down?
- Prestige Consumer Healthcare (PBH) reports total revenues by business across 2 parts — International OTC Healthcare and North American OTC Healthcare. Each is extracted from the segment footnotes and tracked over time.
- Where does Prestige Consumer Healthcare's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Prestige Consumer Healthcare's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.